Cell Processing Systems (Sepax, Prodigy, etc)

Cell processing systems are fully automated platforms designed to streamline the isolation, enrichment, expansion, and purification of cells in applications such as cell therapy manufacturing, regenerative medicine, and immuno-oncology research. These advanced systems—exemplified by devices like Sepax, CliniMACS Prodigy, and other modular instruments—are essential for enabling GMP-compliant, closed-system processing of patient- or donor-derived cells while reducing manual handling, contamination risk, and operator variability. Used across CAR-T cell therapy, stem cell transplantation, dendritic cell vaccines, and mesenchymal stromal cell (MSC) expansion, cell processing systems support workflows from raw material input to ready-to-infuse or cryopreserved cell products. These instruments automate critical steps such as density gradient centrifugation, magnetic cell selection, cell washing, buffer exchanges, concentration, and formulation, all within a sealed, sterile environment. Their closed architecture allows processing in classified and non-classified spaces, reducing the need for cleanroom infrastructure and streamlining facility design. Many systems integrate real-time monitoring, programmable protocols, disposable kits, and barcode tracking, ensuring consistent processing, data integrity, and traceability. Operators can execute complex workflows with minimal intervention, saving time and improving batch-to-batch reproducibility. Some platforms also enable multi-step processing, including transduction, expansion, and harvest, without the need to transfer the product between devices—preserving viability and sterility throughout. Cell processing systems support both autologous and allogeneic therapy development, providing flexibility for clinical trials, personalized medicine, and scalable commercial production. Their design aligns with regulatory expectations for advanced therapy medicinal products (ATMPs) and biologics license applications (BLAs). At Wasteless Bio, we offer surplus and refurbished cell processing systems from leading global manufacturers. Each listing includes technical specifications such as processing capacity, compatible cell types, automation features, disposables format, and GMP-readiness. By sourcing these systems through Wasteless Bio, labs and therapy developers can access cost-effective, high-performance solutions while promoting sustainable, closed-system biomanufacturing in next-generation cell therapies.